Corteva, Inc. $CTVA Shares Sold by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC lessened its stake in Corteva, Inc. (NYSE:CTVA) by 52.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 17,289 shares of the company’s stock after selling 19,076 shares during the quarter. Chesley Taft & Associates LLC’s holdings in Corteva were worth $1,159,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CTVA. Activest Wealth Management grew its position in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC acquired a new position in shares of Corteva during the 3rd quarter worth about $25,000. True Wealth Design LLC raised its position in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares during the last quarter. Total Investment Management Inc. purchased a new position in Corteva in the 2nd quarter valued at about $27,000. Finally, Twin Peaks Wealth Advisors LLC purchased a new position in Corteva in the 2nd quarter valued at about $29,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Up 0.0%

CTVA stock opened at $82.00 on Monday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm has a 50-day moving average of $76.25 and a two-hundred day moving average of $69.65. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $82.89. The company has a market cap of $55.05 billion, a price-to-earnings ratio of 51.90, a PEG ratio of 2.80 and a beta of 0.72.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were paid a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is 45.57%.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Royal Bank Of Canada raised their target price on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Oppenheimer set a $86.00 price target on Corteva in a research note on Thursday, February 5th. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and boosted their price target for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Finally, Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $82.90.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.14% of the stock is currently owned by insiders.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.